Second Primary Cancers in Subsites of Colon and Rectum in Patients With Previous Colorectal Cancer

BACKGROUND: Compared with the general population, patients with a previous colorectal cancer are at higher risk for a second colorectal cancer, but detailed risk analysis by subsite is scarce. OBJECTIVE: Our goal was to investigate the risk of a second cancer in relation to subsite as a basis for planning surveillance strategies,. DESIGN, SETTING, AND PATIENTS: This was a retrospective analysis of a prospectively designed, population-based cancer registry (The Netherlands Cancer Registry). Patients with a stage I, II, or III colorectal cancer diagnosed between 1989 and 2008 were included. MAIN OUTCOME MEASURES: Cumulative incidence, standardized incidence ratio, and absolute excess risk for second primary cancers in subsites of the colon and rectum were estimated for follow-up periods of 2 to 5, 6 to 10, and more than 10 years after the index cancer in patients older than 50 years and in those aged 50 years or younger. RESULTS: A total of 123,347 patients had a first invasive colorectal cancer diagnosed between 1989 and 2008. Of these, 1849 patients (1.5%) had a second colorectal lesion that was found more than 1 year after the initial cancer and diagnosed as a second primary colorectal cancer. In patients older than 50 years, the 20-year cumulative incidence for second cancers was 3.4% in the proximal colon, 1.2% in the distal colon, and 1.2% in the rectum. More than 60% of second cancers occurred within 5 years after the index cancer. The standardized incidence ratio was highest in the proximal-colon (1.9; 95% CI, 1.8–2.0), followed by the distal-colon (1.0, 95% CI, 0.9–1.1), and the rectum (0.9, 95% CI, 0.8–1.0). The corresponding absolute excess risks per 10 000 person years were 9 in the proximal colon, 0.1 in the distal colon, and 1 in the rectum. After 5 years of follow-up, elevated risk was observed only in the proximal colon. A similar risk pattern was observed in patients younger than 50 years. The absolute excess risk for a second cancer in the proximal colon increased over time. The proportion of stage III and stage IV second cancers increased from 31% during the first 5 years of follow-up to 38% after 10 years of follow-up. LIMITATIONS: Limitations of this study included lack of data regarding polypectomy rates and interval of surveillance colonoscopies. CONCLUSIONS: Compared with the general population, individuals with previous colorectal cancer have a higher risk for a second cancer in all subsites of the colon and rectum. Among long-term survivors older than 50 years, risk remains elevated only in the proximal colon. Further studies should be encouraged to develop a suitable surveillance method for aging, high-risk, long-term colorectal cancer survivors.

[1]  H. Brenner,et al.  Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study , 2012, International journal of cancer.

[2]  C. Hassan,et al.  Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis , 2011, Gut.

[3]  L. Walter,et al.  Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. , 2011, Gastrointestinal endoscopy.

[4]  J. Coebergh,et al.  Prevalence of multiple malignancies in the Netherlands in 2007 , 2011, International journal of cancer.

[5]  J. Zell,et al.  Risk of second primary colorectal cancer among colorectal cancer cases: A population-based analysis , 2011, Journal of carcinogenesis.

[6]  Harminder Singh,et al.  Rate and Predictors of Early/Missed Colorectal Cancers After Colonoscopy in Manitoba: A Population-Based Study , 2010, The American Journal of Gastroenterology.

[7]  S Siesling,et al.  Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  J. Coebergh,et al.  Trends in colorectal cancer in the south of the Netherlands 1975–2007: Rectal cancer survival levels with colon cancer survival , 2010, Acta oncologica.

[9]  F. Bray,et al.  Trends in colorectal cancer incidence in Norway 1962–2006: an interpretation of the temporal patterns by anatomic subsite , 2010, International journal of cancer.

[10]  A. Stang,et al.  Etiologic Insights From Surface Adjustment of Colorectal Carcinoma Incidences: An Analysis of the U.S. SEER Data 2000–2004 , 2008, The American Journal of Gastroenterology.

[11]  Jun Kato,et al.  Differences between right‐ and left‐sided colon cancer in patient characteristics, cancer morphology and histology , 2008, Journal of gastroenterology and hepatology.

[12]  Charles J. Kahi,et al.  Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi‐Society Task Force on Colorectal Cancer * † , 2006, CA: a cancer journal for clinicians.

[13]  Charles J. Kahi,et al.  Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. , 2006, Gastroenterology.

[14]  M. Janssen-Heijnen,et al.  Co‐morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer , 2005, The British journal of surgery.

[15]  C. Earle,et al.  Follow-up of patients with curatively resected colorectal cancer: a practice guideline , 2003, BMC Cancer.

[16]  J. Little,et al.  Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. , 2003, Gastroenterology.

[17]  M. Egger,et al.  Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials , 2002, BMJ : British Medical Journal.

[18]  E. G. Hahn,et al.  Right-sided shift found in metachronous colorectal adenomas. , 2001, Endoscopy.

[19]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[20]  S N Thibodeau,et al.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.

[21]  B. Leggett,et al.  Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance , 1997, Diseases of the colon and rectum.

[22]  J A Knottnerus,et al.  Completeness of cancer registration in Limburg, The Netherlands. , 1993, International journal of epidemiology.

[23]  I sabel Mortara,et al.  International Union against Cancer , 1938, Nature.

[24]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[25]  A. Umar Lynch syndrome (HNPCC) and microsatellite instability analysis guidelines. , 2006, Cancer biomarkers : section A of Disease markers.

[26]  International rules for multiple primary cancers (ICD-0 third edition). , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[27]  J. Coebergh,et al.  Incidence of Cancer in the Netherlands 1998 , 2002 .

[28]  J. Coebergh,et al.  Incidence of cancer in the Netherlands. , 2001 .

[29]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.